CLINICO-HAEMATOLOGIC PARAMETERS AND ASSESSMENT OF POST-INDUCTION STATUS IN ACUTE LYMPHOBLASTIC LEUKEMIA
Keywords:Key words: Acute Lymphoblastic Leukemia, Clinical features, haematologic parameters, post-induction remission status
AbstractBackground: Acute Leukaemia is a malignant disorder characterized by an abnormal proliferation of immature cells, called blasts. Classically, acute leukaemia is classified into acute myeloid leukaemia and acute lymphoblastic leukaemia depending on the lineage of the immature cells. Objective of the study was to evaluate the clinical presentations, analyze the haematologic parameters at time of diagnosis and assess the post-induction status in newly diagnosed ALL patients. This cross-sectional study was conducted in the Department of Haematology, Armed Forces Institute of Pathology, Rawalpindi from June to November 2019. Methods: A total of 55 newly diagnosed ALL patients were recruited including children, adults and elderly. Detailed medical history and physical findings were noted. Haematologic parameters were documented. Each patient was treated as per standard protocol and remission induction status was determined on day 29 of treatment. Results: The median age of the study cohort of 55 newly diagnosed ALL patients was 8.5 years. Males were 37 (67.3%) and females were 18 (32.7%) with a male to female ratio of 2:1. Paediatric group included 31 (56.4%) patients. Nine (16.4%) patients were in the adult group and 15 (27.3%) in the elderly age group. The time from onset of symptoms to diagnosis of acute lymphoblastic leukaemia was 98.87±79.21 days. Fever was the most common symptom but body aches were common among paediatric group while pallor was the most common sign. Mean WBC was 29.1±27.9 x109/l, Hb was 8.1±2.9 g/dl and platelet count was 60±41.8 x109/l B-acute lymphoblastic leukaemia was more common than T-acute lymphoblastic leukaemia. A total of 52 patients were assessed on day 29 to evaluate for post-induction remission status. The remission rate of our cohort of patients was 82.7%. Conclusion: Most of the patients were in paediatric age group and remission rate was better in this age group compared to elderly population. B-ALL was associated with good response to induction chemotherapy while patients with BCR-ABL1 gene rearrangement did not respond well to treatment. Identification of prognostic features at diagnosis will further help our clinicians to predict outcomes of the disease.
Inaba H, Mullighan CG. Pediatric acute lymphoblastic leukaemia. Haematologica 2020;105(11):2524–39.
Imai K. [Acute lymphoblastic leukaemia: pathophysiology and current therapy]. Rinsho Ketsueki 2017;58(5):460–70.
Aldoss I, Forman SJ, Pullarkat V. Acute Lymphoblastic Leukaemia in the Older Adult. J Oncol Pract 2019;15(2):67–75.
Coccaro N, Anelli L, Zagaria A, Specchia G, Albano F. Next-Generation Sequencing in Acute Lymphoblastic Leukaemia. Int J Mol Sci 2019;20(12):2929.
Terwilliger T, Abdul-Hay M. Acute lymphoblastic leukaemia: A comprehensive review and 2017 update. Blood Cancer J 2017;7:e577.
Inaba H, Greaves M, Mullighan CG. Acute lymphoblastic leukaemia. Lancet 2013;381(9881):1943–55.
Hoelzer D, Bassan R, Dombret H, Fielding A, Ribera JM, Buske C. Acute lymphoblastic leukaemia in adult patients: ESMO. Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2016;27(Suppl 5):v69–82.
Chiaretti S, Zini G, Bassan R. Diagnosis and subclassification of acute lymphoblastic leukaemia. Mediterr J Hematol Infect Dis 2014;6(1):e2014073.
Chen B, Wang YY, Shen Y, Zhang WN, He HY, Zhu YM, et al. Newly diagnosed acute lymphoblastic leukaemia in China (I): abnormal genetic patterns in 1346 childhood and adult cases and their comparison with the reports from Western countries. Leukaemia 2012;26(7):1608–16.
Gao C, Zhao XX, Li WJ, Cui L, Zhao W, Liu SG, et al. Clinical features, early treatment responses and outcomes of pediatric acute lymphoblastic leukaemia in China with or without specific fusion transcripts: a single institutional study of 1,004 patients. Am J Hematol 2012;87(11):1022–7.
Abbasi S, Maleha F, Shobaki M. Acute lymphoblastic leukaemia experience: epidemiology and outcome of two different regimens. Mediterr J Hematol Infect Dis 2013;5(1):e2013024.
Pui CH, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet 2008;371(9617):1030–43.
Goujon‑Bellec S, Mollie A, Rudant J, Guyot‑Goubin A, Clavel J. Time trends and seasonal variations in the diagnosis of childhood acute lymphoblastic leukaemia in France. Cancer Epidemiol 2013;37(3):255–61.
Medinger M, Heim D, Lengerke C, Halter JP, Passweg JR. Akute Lymphoblastische Leukämie – Diagnostik und Therapie [Acute lymphoblastic leukaemia - diagnosis and therapy]. Ther Umsch 2019;76(9):510–5.
Kato M, Manabe A. Treatment and biology of pediatric acute lymphoblastic leukaemia. Pediatr Int 2018;60(1):4–12.
Paul S, Kantarjian H, Jabbour EJ. Adult Acute Lymphoblastic Leukaemia. Mayo Clin Proc 2016;91(11):1645–66.
Pui CH. Precision medicine in acute lymphoblastic leukaemia. Front Med 2020;14(6):689–700.
Advani A. Acute lymphoblastic leukaemia (ALL). Best Pract Res Clin Haematol 2017;30(3):173–4.
Kansagra A, Dahiya S, Litzow M. Continuing challenges and current issues in acute lymphoblastic leukaemia. Leuk Lymphoma 2018;59(3):526–41.
Li SY, Ye JY, Meng FY, Li CF, Yang MO. Clinical characteristics of acute lymphoblastic leukaemia in male and female patients: A retrospective analysis of 705 patients. Oncol Lett 2015;10(1):453–8.
Karimi M, Yarmohammadi H. Seasonal variations in the onset of childhood leukaemia/lymphoma: April 1996 to March 2000, Shiraz, Iran. Hematol Oncol 2003;21(2):51–5.
Matsumura T, Kami M, Yamaguchi T, Yuji K, Kusumi E, Taniguchi S, et al. Allogeneic cord blood transplantation for adult acute lymphoblastic leukaemia: retrospective survey involving 256 patients in Japan. Leukaemia 2012;26(7):1482–6.
Schrappe M, Hunger SP, Pui CH, Saha V, Gaynon PS, Baruchel A, et al. Outcomes after induction failure in childhood acute lymphoblastic leukaemia. N Engl J Med 2012;366(15):1371–81.
Lustosa de Sousa DW, de Almeida Ferreira FV, Cavalcante Félix FH, de Oliveira Lopes MV. Acute lymphoblastic leukaemia in children and adolescents: prognostic factors and analysis of survival. Rev Bras Hematol Hemoter 2015;37(4):223–9.
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.